Reference no: EM133449139
Question: Mehmet Yavuz is 62 yo. He presented to the clinic and after having an HbA1c test (result 9%) was diagnosed with type 2 Diabetes mellitus.
His cardiovascular risk was > 15%
His renal health screen showed an eGFR 90 mL/min/1.73m2 with microalbuminuria of 3.5 mg/mmol.
He attended a podiatry appointment which detected decreased dorsalis pedis and posterior tibialis pulses in both legs .
Management of his condition now includes the following:
Exercise: at least 150 minutes of aerobic and 60 minutes of resistance exercise each week
Diet: a plan worked out with an accredited dietician based on the Australian Dietary Guidelines (2013).
Drug use: smoking cessation plan to stop cigarette use; alcohol consumption reduction to 1 - 2 full strength beers every second day
Weight loss: Mehmet aims to lose 5 kg over the first 6 - 8 weeks after diagnosis
Medications:
Jardiamet (empagliflozin 5mg, metformin 500 mg), twice daily, with or after food
ramipril 5 mg, daily
Rosuzet (rosuvastatin 20mg, ezetimibe 10mg), daily
Ongoing diagnostics:
HbA1c: every 3 months
lipid profile: every 3 months
renal function assessment: annually
podiatrist assessment: at least once a year
optometrist assessment: at least once a year
Please discuss the intervention below in context of Mehmet with recent australian guidelines
ramipril
You need to do the following for the above medication:
describe the mechanism of ACTION/S
identify the AIM of each therapy for Mehmet
relate each therapy to Mehmet's pathophysiological presentation
refer briefly to any GUIDELINES which support the use of each medication
identify one RISK or special consideration for Mehmet whilst taking each medication
identify what evidence will demonstrate the EFFECTIVENESS of each therapy if you were evaluating care provided to Mehmet